Collection: RET/PTC and BRAF
-
Sorafenib Soranni SORAFENIB TOSYLATE 200 MG 56 tablets Approval No. 09 L 0700/16 Valid until 27-6-2026
Regular price ¥525.00 CNYRegular priceUnit price / per¥1,000.00 CNYSale price ¥525.00 CNYSale -
Sorafenib 1. Unresectable hepatocellular carcinoma. 2. Advanced renal cell carcinoma. 3. Locally recurrent or metastatic, progressive, differentiated thyroid cancer resistant to radioactive iodine therapy.
Regular price ¥630.00 CNYRegular priceUnit price / per¥900.00 CNYSale price ¥630.00 CNYSale